<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00298844</url>
  </required_header>
  <id_info>
    <org_study_id>021</org_study_id>
    <nct_id>NCT00298844</nct_id>
  </id_info>
  <brief_title>Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus</brief_title>
  <official_title>Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus: Left Ventricular Diastolic Dysfunction, Myocardial Ischemia and Peripheral Vascular Insufficient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <brief_summary>
    <textblock>
      The study aim is to establish a consecutive population of newly referred type 2 diabetes
      mellitus patients and among these to describe the degree of macrovascular disease by
      evaluating left ventricular systolic and diastolic function (echocardiography), myocardial
      perfusion (single-photon emission computed tomography (SPECT)), the peripheral vascular
      perfusion (strain gauge toe blood pressure measurements and a ultrasound scan of the a.
      carotis communis). Further, the degree of microvascular disease will be evaluated (glomerular
      filtration rate assessment, fundus photography and biotesiometry). Finally the cohort will be
      followed the next two years to assess the prognostic value of the above-mentioned parameters
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>350</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: â‰¥ 20 years.

          -  Fasting C-peptide &gt; 300 pmol/l.

        Exclusion Criteria:

          -  Verified medical history of macrovascular disease (stroke, myocardiac infarct,
             coronary revascularisation or strain gauge toe blood pressure &lt; 30 mmHg).

          -  Suspected short lifespan because of malignant disease or end-stage kidney disease.

          -  Pregnancy or planned pregnancy during the study period.

          -  Body weight &gt; 150 kg.

          -  Physical or mental disability not enabling participation in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mikael K. Poulsen, PhD student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mikael K. Poulsen, PhD student</last_name>
    <phone>+45 65414365</phone>
    <email>doc_mkp@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan E. Henriksen, MD, PhD</last_name>
    <phone>+45 65414364</phone>
    <email>jan.erik.henriksen@ouh.fyns-amt.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikael K. Poulsen, PhD student</last_name>
      <phone>+45 6541 4365</phone>
      <email>doc_mkp@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jan Erik Henriksen, MD, PhD</last_name>
      <phone>+45 6541 4364</phone>
      <email>jan.erik.henriksen@ouh.fyns-amt.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Mikael K Poulsen, PhD student</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2006</study_first_submitted>
  <study_first_submitted_qc>March 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2006</study_first_posted>
  <last_update_submitted>March 22, 2007</last_update_submitted>
  <last_update_submitted_qc>March 22, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2007</last_update_posted>
  <keyword>Type 2 diabetes mellitus</keyword>
  <keyword>Macrovascular disease</keyword>
  <keyword>Diastolic dysfunction</keyword>
  <keyword>Intima media thickness</keyword>
  <keyword>Single- photon emission computed tomography (SPECT)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

